← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.6M of Moderna, Inc.

Sold$1,603,500
$160.35Price
10,000Shares

What MRNA did after the filing

Filed Feb 24Copier in Feb 27
The stock from Mon, Feb 27 open, $139.52
+11.3%
S&P 500, same days
+2.9%

Measured over 30 trading days, to the Apr 11 close.

Traded Wed, Feb 22. Filed Fri, Feb 24, 7:30 PM ET, after the close. Returns use the Feb 27 open and the Apr 11 close. Not investment advice.